Schizophrenia Support Forum
EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan -
News on schizophrenia and mental health matters
everhopeful
January 8, 2026, 5:47pm
1
9 Likes
Related topics
Topic
Replies
Views
Activity
FDA hits Newron’s phase 3 schizophrenia trial with clinical hold in US after patient death
News on schizophrenia and mental health matters
0
51
May 3, 2026
Newron Fortifies Evenamide Phase III Push with Fresh Capital, Patent Win and Board Overhaul
News on schizophrenia and mental health matters
4
55
March 27, 2026
Newron Pharmaceuticals Secures Up To €38 Million To Advance Phase III Evenamide Program
News on schizophrenia and mental health matters
3
84
February 25, 2026
Adjunctive treatment with evenamide, a glutamate modulator, is associated with clinically meaningful benefits in patients with treatment-resistant schizophrenia and inadequate response to antipsychotics
Medications
2
78
February 9, 2026
FDA recommends another large trial for new schizophrenia drug
News on schizophrenia and mental health matters
1
55
December 23, 2025